• OPEN AN ACCOUNT
Indian Indices
Sensex
72,771.72 -1,124.02
( -1.52%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,234.37 -129.83
(-0.20%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.9539136
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
151.3
100395.34
EPS(TTM)
Face Value()
Div & Yield %
7.95
1
0.67
 

Hybrid Financial Services standalone net profit declines 58.88% in the March 2026 quarter
May 21,2026
Net profit of Hybrid Financial Services declined 58.88% to Rs 0.44 crore in the quarter ended March 2026 as against Rs 1.07 crore during the previous quarter ended March 2025. Sales declined 40.82% to Rs 1.16 crore in the quarter ended March 2026 as against Rs 1.96 crore during the previous quarter ended March 2025.

For the full year,net profit declined 29.69% to Rs 2.70 crore in the year ended March 2026 as against Rs 3.84 crore during the previous year ended March 2025. Sales declined 11.68% to Rs 5.67 crore in the year ended March 2026 as against Rs 6.42 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.161.96 -41 5.676.42 -12
OPM %-48.2855.61 -30.1653.12 -
PBDT0.481.10 -56 2.834.16 -32
PBT0.441.07 -59 2.704.05 -33
NP0.441.07 -59 2.703.84 -30